Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06748209 · ClinicalTrials.gov registry record · Phase 4
Establishing Mobile Transcranial Magnetic Stimulation
A Phase 4 study of Treatment Resistant Major Depression, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06748209 is a Phase 4 study of Treatment Resistant Major Depression that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06748209, a Phase 4 study of Treatment Resistant Major Depression, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
In this pilot study, investigators propose to design and create a portable TMS unit, in a van, and then test out delivering TMS in three different locations in South Carolina, all affiliated with MUSC and within 2-hours driving from Charleston, SC. This study would test out this new delivery mode, and provide valuable feasibility, safety, and efficacy lessons for later refinement and potential widespread adoption of mobile TMS as a treatment option, both in our state and across the US.
Conditions Studied
Interventions
- DEVICE Left prefrontal Transcranial Magnetic Stimulation (TMS)
- DEVICE FDA cleared TMS for treating depression
Study Locations (1)
South Carolina
- Medical Univerity of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-05-10 |
| Est. Completion | 2028-03-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06748209
The ClinicalTrials.gov registry entry for NCT06748209 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Treatment Resistant Major Depression appearing as the primary indexed condition, and to 2 interventions - of which Left prefrontal Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT06748209 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT06748209 about?
NCT06748209 is a clinical study titled "Establishing Mobile Transcranial Magnetic Stimulation". In this pilot study, investigators propose to design and create a portable TMS unit, in a van, and then test out delivering TMS in three different locations in South Carolina, all affiliated with MUSC and within 2-hours driving from Charleston, SC. This study would test out this new delivery mode, a...
What is the current status of trial NCT06748209?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2025-05-10. Estimated completion is 2028-03-01.
What conditions does trial NCT06748209 study?
This clinical trial studies the following conditions: Treatment Resistant Major Depression.
What interventions are being tested in trial NCT06748209?
The interventions under investigation include: Left prefrontal Transcranial Magnetic Stimulation (TMS) (DEVICE), FDA cleared TMS for treating depression (DEVICE).
Who is sponsoring clinical trial NCT06748209?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06748209 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.